Robert Benamouzig

Summary

Country: France

Publications

  1. doi request reprint Identification and chemoprevention in subjects at moderate risk of colorectal cancer
    Robert Benamouzig
    Department of Gastroenterology, AP HP, Avicenne Hospital, 125 rue de Stalingrad, Bobigny, France
    Best Pract Res Clin Gastroenterol 25:631-40. 2011
  2. doi request reprint Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial
    Robert Benamouzig
    Department of Gastroenterology, AP HP, Avicenne Hospital, Paris 13 University, Bobigny, France
    Gut 61:255-61. 2012
  3. doi request reprint Cyclooxygenase-2 expression and recurrence of colorectal adenomas: effect of aspirin chemoprevention
    Robert Benamouzig
    Department of Gastroenterology, AP HP, Hopital Avicenne, 125 route de Stalingrad, Bobigny, France
    Gut 59:622-9. 2010
  4. ncbi request reprint Low dose aspirin, COX-inhibition and chemoprevention of colorectal cancer
    Robert Benamouzig
    Department of Gastro enterology, Hopital Avicenne, 125 rue de Stalingrad, 93009 Bobigny Cedex, France
    Curr Top Med Chem 5:493-503. 2005
  5. ncbi request reprint Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial
    Robert Benamouzig
    Department of Gastroenterology, Avicenne Hospital, AP HP, Paris 13 University, Bobigny Cedex, France
    Gastroenterology 125:328-36. 2003
  6. ncbi request reprint Calcium supplementation for preventing colorectal cancer: where do we stand?
    Robert Benamouzig
    Department of Gastroenterology, Avicenne Hospital, AP HP, Paris 13 University, 93009 Bobigny Cedex, France
    Lancet 364:1197-9. 2004
  7. ncbi request reprint [Chemopreventive agents in colorectal cancer]
    Robert Benamouzig
    Service de Gastro Enterologie, Hopital Avicenne, Bobigny
    Rev Prat 53:2213-4. 2003
  8. ncbi request reprint [Inter-observer agreement on histological diagnosis of colorectal polyps: the APACC study]
    Hachung Yoon
    Service de Gastro Enterologie, Hopital Avicenne, 125, rue de Stalingrad, 93009 Bobigny Cedex, France
    Gastroenterol Clin Biol 26:220-4. 2002
  9. ncbi request reprint Is colorectal cancer an avoidable disease nowadays?
    Robert Benamouzig
    Department of Gastroenterology, Hopital Avicenne, 125 route de Stalingrad, 93000 Bobigny, France
    Best Pract Res Clin Gastroenterol 18:107-11. 2004
  10. doi request reprint Prevalence and co-occurrence of upper and lower functional gastrointestinal symptoms in patients eligible for bariatric surgery
    Marinos Fysekidis
    Diabetes, Nutrition and Endocrinology Department, Avicenne Hospital, Bobigny, France
    Obes Surg 22:403-10. 2012

Collaborators

Detail Information

Publications19

  1. doi request reprint Identification and chemoprevention in subjects at moderate risk of colorectal cancer
    Robert Benamouzig
    Department of Gastroenterology, AP HP, Avicenne Hospital, 125 rue de Stalingrad, Bobigny, France
    Best Pract Res Clin Gastroenterol 25:631-40. 2011
    ..In the present article, we will try to better define these particular situations and discuss the risk quantification and the expected chemoprevention contribution...
  2. doi request reprint Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial
    Robert Benamouzig
    Department of Gastroenterology, AP HP, Avicenne Hospital, Paris 13 University, Bobigny, France
    Gut 61:255-61. 2012
    ..In this study the results of daily intake of low-dose aspirin on polyp recurrence at 4-year follow-up are presented...
  3. doi request reprint Cyclooxygenase-2 expression and recurrence of colorectal adenomas: effect of aspirin chemoprevention
    Robert Benamouzig
    Department of Gastroenterology, AP HP, Hopital Avicenne, 125 route de Stalingrad, Bobigny, France
    Gut 59:622-9. 2010
    ..Low-dose aspirin reduces the incidence of colorectal cancer and recurrence of adenomas. Cyclooxygenase-2 (COX-2), one of its main target enzymes, is reportedly over-expressed in colorectal adenomas...
  4. ncbi request reprint Low dose aspirin, COX-inhibition and chemoprevention of colorectal cancer
    Robert Benamouzig
    Department of Gastro enterology, Hopital Avicenne, 125 rue de Stalingrad, 93009 Bobigny Cedex, France
    Curr Top Med Chem 5:493-503. 2005
    ..Four RCTs of the effect of aspirin on adenoma recurrence are available. Other trials are currently underway...
  5. ncbi request reprint Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial
    Robert Benamouzig
    Department of Gastroenterology, Avicenne Hospital, AP HP, Paris 13 University, Bobigny Cedex, France
    Gastroenterology 125:328-36. 2003
    ..Epidemiologic and experimental studies have suggested that aspirin intake reduces the risk for colorectal carcinogenesis. However, the available data are not sufficient to serve as the basis for firm recommendations...
  6. ncbi request reprint Calcium supplementation for preventing colorectal cancer: where do we stand?
    Robert Benamouzig
    Department of Gastroenterology, Avicenne Hospital, AP HP, Paris 13 University, 93009 Bobigny Cedex, France
    Lancet 364:1197-9. 2004
  7. ncbi request reprint [Chemopreventive agents in colorectal cancer]
    Robert Benamouzig
    Service de Gastro Enterologie, Hopital Avicenne, Bobigny
    Rev Prat 53:2213-4. 2003
  8. ncbi request reprint [Inter-observer agreement on histological diagnosis of colorectal polyps: the APACC study]
    Hachung Yoon
    Service de Gastro Enterologie, Hopital Avicenne, 125, rue de Stalingrad, 93009 Bobigny Cedex, France
    Gastroenterol Clin Biol 26:220-4. 2002
    ..Their interpretations were compared to those of the study's consensual diagnosis performed by two reference pathologists...
  9. ncbi request reprint Is colorectal cancer an avoidable disease nowadays?
    Robert Benamouzig
    Department of Gastroenterology, Hopital Avicenne, 125 route de Stalingrad, 93000 Bobigny, France
    Best Pract Res Clin Gastroenterol 18:107-11. 2004
    ..Chemoprevention of colorectal cancer that involves the long-term use of pharmacological agents as aspirin also seems to be effective...
  10. doi request reprint Prevalence and co-occurrence of upper and lower functional gastrointestinal symptoms in patients eligible for bariatric surgery
    Marinos Fysekidis
    Diabetes, Nutrition and Endocrinology Department, Avicenne Hospital, Bobigny, France
    Obes Surg 22:403-10. 2012
    ..The aim of the present study was to evaluate the prevalence and the association of functional digestive symptoms affecting the upper and the lower digestive tract in patients eligible for bariatric surgery...
  11. ncbi request reprint [NSAID, type 2 cyclo-oxygenase inhibitors and pancreatic carcinogenesis]
    Gaetan des Guetz
    Service d Oncologie Medicale, Hopital Avicenne, Bobigny, France
    Gastroenterol Clin Biol 29:411-4. 2005
  12. doi request reprint Comparison of FDG-PET/CT and MR with diffusion-weighted imaging for assessing peritoneal carcinomatosis from gastrointestinal malignancy
    Michael Soussan
    Department of Nuclear Medicine, Universite Paris 13, CHU Avicenne, 125 rue de Stalingrad, 93000, Bobigny, France
    Eur Radiol 22:1479-87. 2012
    ..To assess the accuracy of FDG-PET/CT and MR with diffusion-weighted imaging (MR-DWI) for diagnosing peritoneal carcinomatosis (PC) from gastrointestinal malignancies...
  13. doi request reprint Postprandial protein metabolism but not a fecal test reveals protein malabsorption in patients with pancreatic exocrine insufficiency
    Gheorghe Airinei
    Gastroenterology Unit, CRNH IdF, AP HP, University Paris 13, Hopital Avicenne, Bobigny, France
    Clin Nutr 30:831-7. 2011
    ..We investigated this question in patients with chronic pancreatitis, both in the absence and presence of enzyme therapy, using a stable isotope sensitive method...
  14. doi request reprint Treatment of refractory irritable bowel syndrome with visceral osteopathy: Short-term and long-term results of a randomized trial
    Thu Van Attali
    Service de Gastroenterologie, Hopital Avicenne, Bobigny, France
    J Dig Dis 14:654-61. 2013
    ..The aim of this study was to evaluate the effectiveness of visceral osteopathy for IBS...
  15. ncbi request reprint Expression of ghrelin in fundus is increased after gastric banding in morbidly obese patients
    Bernard Uzzan
    Department of Pharmacology Hormonology, Hopital Avicenne, Assistance Publique Hopitaux de Paris, Bobigny, France
    Obes Surg 17:1159-64. 2007
    ..In this study, we assessed serum ghrelin level and gastric fundus expression before and 1 year after LAGB...
  16. ncbi request reprint Simultaneous decompression colonoscopy and radiologic G-tube insertion in a patient with megacolon because of chronic colonic pseudo-obstruction
    Alain Attar
    Hopital Avicenne, Bobigny
    Gastrointest Endosc 62:975-6; discussion 976. 2005
  17. ncbi request reprint [Buerger's disease or thromboangiitis obliterans revealed by an enteric ischemia. Case report and literature review]
    Camilo Adem
    Service d Anatomie Pathologique, Hopital Avicenne, 125, rue de Stalingrad, 93009 Bobigny Cedex, France
    Gastroenterol Clin Biol 26:409-11. 2002
    ..Histopathological findings were consistent with thromboangiitis obliterans. Unexplained abdominal pain, even if inaugural, in young male smokers, should evoke the possibility of Buerger's disease...
  18. doi request reprint Beneficial effects of an amino acid mixture on colonic mucosal healing in rats
    Xinxin Liu
    UMR 914 PNCA INRA, AgroParisTech Physiologie de la Nutrition et du Comportement Alimentaire, Paris, France Service d Anatomie et Cytologie Pathologique, Hôpital Xavier Bichat, Paris, France INSERM U773, Centre de Recherche Biomédicale Bichat Beaujon Université Paris 7, Paris, France Frontier Research Laboratory, Institute for Innovation, Ajinomoto Co Inc, Kawasaki, Japan and Departement de Gastroentérologie, Hopital Avicenne, Assistance Publique Hopitaux de Paris, Bobigny, France
    Inflamm Bowel Dis 19:2895-905. 2013
    ..Here, we investigated the effect of an amino acid mixture supplement on rat MH...
  19. doi request reprint Deficient mismatch repair phenotype is a prognostic factor for colorectal cancer in elderly patients
    Thomas Aparicio
    Gastroenterology, Avicenne Hospital, APHP, Universite Paris 13, Bobigny, France
    Dig Liver Dis 45:245-50. 2013
    ..The frequency of deficient DNA mismatch repair tumours increases with age due to the hypermethylation of hMLH1 promoter. The study aimed to determine the prognostic value of deficient DNA mismatch repair phenotype in elderly patients...